Functional Precision Medicine by Design

Targeted therapies do not work for everyone

Single Drug Therapies
20%
Targeted Therapies
25-75%
Immunotherapies
20-40%

Every 4 week delay in cancer treatment causes up to 28% increase in mortality risk.

Murumägi, A., Ungureanu, D., Khan, S. et al. Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer. Br J Cancer 128, 678–690 (2023).​

It's all possible now
through Nine Diagnostics.

A faster path to the most effective treatment with better outcomes

We develop holistic profiles based on a patient’s personal health data, demographics, social determinants of health, and other relevant factors pertinent to the ultimate outcomes.
Multidimensional datasets are acquired from fluorescent emissions using an array of nanoscale sensing elements that detect health abnormalities and signals of treatment effectiveness in small patient samples.​
Get patients the most effective treatment faster by providing feedback to select and optimize treatment faster.
Researchers and drug developers can now understand new biology with biomarkers that react dynamically, in real time, directly from patients.
Clinicians can accelerate validation of precision medical treatments in real patient situations.
Patients ultimately get the most effective treatment as soon as possible.

Shorter closed feedback loops save lives

golden-ticket-16-9-low-res.png.corpimgo
MDSS_2
CancerHackerLab

Functional Precision Medicine by Design

Determining treatment effectiveness, discovering new biology using AI enabled nanosensor technology.

Follow Us
Linkedin Facebook X-twitter Threads Instagram
Join Us

Interested in collaborating, investing, or working with us? Contact us at info@ninediagnosics.xyz!

Copyright © 2024 Nine Diagnostics